Session (CTI)

PURPOSE: Real-world evidence (RWE) is increasingly used by regulators in shaping healthcare decisions, offering valuable insights into medication safety and treatment effectiveness across diverse populations. The Nordic countries, with their comprehensive nationwide registries, and the Asia-Pacific region, with its rapidly expanding healthcare data infrastructure, present unique opportunities for collaboration in generating robust RWE. This session is designed for researchers, regulators, and policymakers interested in leveraging international cooperation to strengthen RWE. Attendees will gain practical insights, establish new connections, and contribute to shaping future research directions in this rapidly evolving field.

DESCRIPTION: This workshop presents existing and potential future Nordic-Asia Pacific collaborations, focusing on how real-world data can be leveraged to address key research questions in perinatal and pediatric health. We will reflect on key lessons from existing collaborations, including data harmonization and methodological innovations. Case studies will highlight successful navigated cross-border research partnerships, demonstrating how diverse healthcare systems and population-based registries have contributed to clinically relevant, high-impact findings. An interactive session will encourage attendees to explore innovative ways to enhance inter-continent partnerships, strengthen institutional ties, and align research priorities between the two regions. Dr van Gelder will start with a brief introduction (5 min). Professor Hsiao will present real-world data sources in the Asia-Pacific region (15 min). Professor Nordeng will follow with RWE activities in Nordic countries and examples of multinational studies in Norway and Asia (15 min). Dr Trinh will present data harmonization efforts to facilitate multinational studies with a focus on OMOP common data model and perinatal expansion tables (10 min). The workshop will be concluded by an interactive session (15 min).